182 related articles for article (PubMed ID: 32518145)
1. Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy.
Buciuc M; Botha H; Murray ME; Schwarz CG; Senjem ML; Jones DT; Knopman DS; Boeve BF; Petersen RC; Jack CR; Petrucelli L; Parisi JE; Dickson DW; Lowe V; Whitwell JL; Josephs KA
Neurology; 2020 Jul; 95(1):e23-e34. PubMed ID: 32518145
[TBL] [Abstract][Full Text] [Related]
2. A multimodal clinical diagnostic approach using MRI and
Lavrova A; Pham NTT; Vernon CJ; Carlos AF; Petersen RC; Dickson DW; Lowe VJ; Jack CR; Whitwell JL; Josephs KA
J Neurol; 2024 Apr; ():. PubMed ID: 38578498
[TBL] [Abstract][Full Text] [Related]
3. FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis.
Botha H; Mantyh WG; Murray ME; Knopman DS; Przybelski SA; Wiste HJ; Graff-Radford J; Josephs KA; Schwarz CG; Kremers WK; Boeve BF; Petersen RC; Machulda MM; Parisi JE; Dickson DW; Lowe V; Jack CR; Jones DT
Brain; 2018 Apr; 141(4):1201-1217. PubMed ID: 29538658
[TBL] [Abstract][Full Text] [Related]
4. White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition.
Raghavan S; Przybelski SA; Reid RI; Lesnick TG; Ramanan VK; Botha H; Matchett BJ; Murray ME; Reichard RR; Knopman DS; Graff-Radford J; Jones DT; Lowe VJ; Mielke MM; Machulda MM; Petersen RC; Kantarci K; Whitwell JL; Josephs KA; Jack CR; Vemuri P
Acta Neuropathol Commun; 2022 Feb; 10(1):16. PubMed ID: 35123591
[TBL] [Abstract][Full Text] [Related]
5. Differentiating the frontal presentation of Alzheimer's disease with FDG-PET.
Woodward MC; Rowe CC; Jones G; Villemagne VL; Varos TA
J Alzheimers Dis; 2015; 44(1):233-42. PubMed ID: 25261443
[TBL] [Abstract][Full Text] [Related]
6. Dichotomous scoring of TDP-43 proteinopathy from specific brain regions in 27 academic research centers: associations with Alzheimer's disease and cerebrovascular disease pathologies.
Katsumata Y; Fardo DW; Kukull WA; Nelson PT
Acta Neuropathol Commun; 2018 Dec; 6(1):142. PubMed ID: 30567576
[TBL] [Abstract][Full Text] [Related]
7. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A(1) receptors using 8-dicyclopropylmethyl-1-[(11)C]methyl-3-propylxanthine PET in Alzheimer's disease.
Fukumitsu N; Ishii K; Kimura Y; Oda K; Hashimoto M; Suzuki M; Ishiwata K
Ann Nucl Med; 2008 Dec; 22(10):841-7. PubMed ID: 19142702
[TBL] [Abstract][Full Text] [Related]
9. Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study.
Josephs KA; Dickson DW; Tosakulwong N; Weigand SD; Murray ME; Petrucelli L; Liesinger AM; Senjem ML; Spychalla AJ; Knopman DS; Parisi JE; Petersen RC; Jack CR; Whitwell JL
Lancet Neurol; 2017 Nov; 16(11):917-924. PubMed ID: 28919059
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.
Jeong Y; Cho SS; Park JM; Kang SJ; Lee JS; Kang E; Na DL; Kim SE
J Nucl Med; 2005 Feb; 46(2):233-9. PubMed ID: 15695781
[TBL] [Abstract][Full Text] [Related]
11. Assessment of dementia risk in aging adults using both FDG-PET and FDDNP-PET imaging.
Ercoli LM; Small GW; Siddarth P; Kepe V; Huang SC; Miller KJ; Lavretsky H; Bookheimer SY; Barrio JR; Silverman DH
Int J Geriatr Psychiatry; 2012 Oct; 27(10):1017-27. PubMed ID: 22383132
[TBL] [Abstract][Full Text] [Related]
12. FDG PET and MRI in logopenic primary progressive aphasia versus dementia of the Alzheimer's type.
Madhavan A; Whitwell JL; Weigand SD; Duffy JR; Strand EA; Machulda MM; Tosakulwong N; Senjem ML; Gunter JL; Lowe VJ; Petersen RC; Jack CR; Josephs KA
PLoS One; 2013; 8(4):e62471. PubMed ID: 23626825
[TBL] [Abstract][Full Text] [Related]
13. Role of β-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment.
Knopman DS; Jack CR; Lundt ES; Wiste HJ; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Machulda MM; Roberts RO; Boeve BF; Jones DT; Petersen RC
JAMA Neurol; 2015 Dec; 72(12):1475-83. PubMed ID: 26437123
[TBL] [Abstract][Full Text] [Related]
14. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
[TBL] [Abstract][Full Text] [Related]
15. Association of TDP-43 Pathology with Global and Regional 18F-Florbetapir PET Signal in the Alzheimer's Disease Spectrum.
Teipel SJ; Temp AGM; Levin F; Dyrba M; Grothe MJ;
J Alzheimers Dis; 2021; 79(2):663-670. PubMed ID: 33337372
[TBL] [Abstract][Full Text] [Related]
16. The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function.
Dowling NM; Johnson SC; Gleason CE; Jagust WJ;
Neuroimage; 2015 Jan; 105():357-68. PubMed ID: 25450107
[TBL] [Abstract][Full Text] [Related]
17. An autopsy case of corticobasal syndrome due to asymmetric degeneration of the motor cortex and substantia nigra with TDP-43 proteinopathy, associated with Alzheimer's disease pathology.
Tando S; Kasai T; Mizuta I; Takahashi H; Yaoi T; Saito K; Hojo T; Mizuno T; Hasegawa M; Itoh K
Neuropathology; 2021 Jun; 41(3):214-225. PubMed ID: 33537992
[TBL] [Abstract][Full Text] [Related]
18. Regional 18F-Fluorodeoxyglucose Hypometabolism is Associated with Higher Apathy Scores Over Time in Early Alzheimer Disease.
Gatchel JR; Donovan NJ; Locascio JJ; Becker JA; Rentz DM; Sperling RA; Johnson KA; Marshall GA;
Am J Geriatr Psychiatry; 2017 Jul; 25(7):683-693. PubMed ID: 28410856
[TBL] [Abstract][Full Text] [Related]
19. Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy.
Josephs KA; Martin PR; Weigand SD; Tosakulwong N; Buciuc M; Murray ME; Petrucelli L; Senjem ML; Spychalla AJ; Knopman DS; Boeve BF; Petersen RC; Parisi JE; Dickson DW; Jack CR; Whitwell JL
Brain; 2020 Dec; 143(11):3463-3476. PubMed ID: 33150361
[TBL] [Abstract][Full Text] [Related]
20. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
